A study showed that treatment of rats with DN with linagliptin, a DPP-4 inhibitor, reduced proteinuria and slowed fibrotic kidney damage without affecting blood glucose levels (Sharkovska et al., 2014). Here, DPP4 is linked to Nephropathy.